Fig. 3From: Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD projectDead-time factor (in arbitrary units—a.u.) of the four Siemens systems used for the clinical part of the MEDIRAD study shown as a function of true count-rate of the systemBack to article page